Jj. Mcsharry et al., Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766,BAY43-9695, and ganciclovir, ANTIM AG CH, 45(10), 2001, pp. 2925-2927
BAY38-4766 and BAY43-9695 are nonnucleosidic compounds with activities agai
nst human cytomegalovirus (HCMV). Two phenotypic assays were used to determ
ine the drug susceptibilities of 36 HCMV clinical isolates to the BAY compo
unds and ganciclovir. Using either assay, both BAY compounds at a concentra
tion of approximately 1 muM inhibited the replication of all 36 HCMV clinic
al isolates, including 11 ganciclovir-resistant clinical isolates, by 50%.